Response by Thuny et al to Letter Regarding Article, "Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity"

被引：1
|
作者：
Thuny, Franck [1 ,2 ,3 ,4 ]
Ederhy, Stephane [5 ]
Escudier, Marion [1 ,2 ,3 ,4 ]
Lalevee, Nathalie [2 ]
Cautela, Jennifer [1 ,2 ,3 ,4 ]
机构：
[1] Aix Marseille Univ, Hop Nord, AP HM,Dept Cardiol, Mediterranean Univ,Cardiooncol Ctr,Unit Heart Fai, Marseille, France
[2] Aix Marseille Univ, Ctr Rech Cardiovasc & Nutr, INSERM 1263, INRA, Marseille, France
[3] Grp Mediterraneen Cardiooncol, Marseille, France
[4] Aix Marseille Univ, AP HM, Oncosaftey Network Early Phases Canc Trials Ctr, Marseille, France
[5] Univ Paris 06, Hop Univ Paris Est, Hop St Antoine, Hop Tenon,AP HP,Inserm 856, Paris, France
来源：
CIRCULATION | 2018年 / 137卷 / 22期
关键词：
MYOCARDITIS;
D O I：
10.1161/CIRCULATIONAHA.118.033783
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2423 / 2424
页数：2
相关论文
共 50 条
  • [21] Immune Checkpoint Inhibitor-Related Cerebellar Toxicity: Clinical Features and Comparison with Paraneoplastic Cerebellar Ataxia
    Dentoni, Marta
    Florean, Irene
    Farina, Antonio
    Joubert, Bastien
    Do, Le-Duy
    Honnorat, Jerome
    Damato, Valentina
    Fabris, Martina
    Gigli, Gian Luigi
    Valente, Mariarosaria
    Vogrig, Alberto
    CEREBELLUM, 2024, 23 (06): : 2308 - 2323
  • [22] Association of Clinical and Radiological Features with Disease Severity of Symptomatic Immune Checkpoint Inhibitor-Related Pneumonitis
    Zhang, Qian
    Tao, Xiuli
    Zhao, Shijun
    Li, Ning
    Wang, Shuhang
    Wu, Ning
    DIAGNOSTICS, 2023, 13 (04)
  • [23] Methodological and reporting issues for meta-analysis of immune checkpoint inhibitor-associated cardiotoxicity. Letter regarding the article 'Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis'
    Chiang, Cho-Han
    Chiang, Cho-Hsien
    Chiang, Cho-Hung
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (06) : 1142 - 1143
  • [24] Mechanisms and Management of Immune Checkpoint Inhibitor-Related Cardiac Adverse Events
    Kadowaki, Hiroshi
    Akazawa, Hiroshi
    Ishida, Junichi
    Komuro, Issei
    JMA JOURNAL, 2021, 4 (02): : 91 - 98
  • [25] Immune checkpoint inhibitor-related pneumonitis: research advances in prediction and management
    Lin, Mei-Xi
    Zang, Dan
    Liu, Chen-Guang
    Han, Xu
    Chen, Jun
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [26] Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
    Vasbinder, Alexi
    Ismail, Anis
    Salem, Joe-Elie
    Hayek, Salim S.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (09) : 959 - 967
  • [27] Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
    Alexi Vasbinder
    Anis Ismail
    Joe-Elie Salem
    Salim S. Hayek
    Current Cardiology Reports, 2023, 25 : 959 - 967
  • [28] Immune Checkpoint Inhibitor-Related Acute Kidney Injury: Management and Challenges
    Youssef, Nada
    Abudayyeh, Ala
    AMERICAN JOURNAL OF NEPHROLOGY, 2025,
  • [29] Incidence of Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Response
    Atchley, William T.
    Rock, Little
    Alvarez, Carolina
    Saxena-Beem, Shruti
    Schwartz, Todd A.
    Ishizawar, Rumey C.
    Patel, Kunal P.
    Rivera, M. Patricia
    CHEST, 2022, 161 (03) : E197 - E197
  • [30] Immune checkpoint inhibitor-related hypophysitis and endocrine dysfunction: clinical review
    Joshi, M. N.
    Whitelaw, B. C.
    Palomar, M. T. P.
    Wu, Y.
    Carroll, P. V.
    CLINICAL ENDOCRINOLOGY, 2016, 85 (03) : 331 - 339
12345